reference/20222368

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20222368

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	132
issn	1432-0843 0344-5704
issueIdentifier	1
pageRange	125-132
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	125
bibliographicCitation	Katsuya Y, Fujiwara Y, Sunami K, Utsumi H, Goto Y, Kanda S, Horinouchi H, Nokihara H, Yamamoto N, Takashima Y, Osawa S, Ohe Y, Tamura T, Hamada A. Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer. Cancer Chemother Pharmacol. 2015 Jul;76(1):125–32. doi: 10.1007/s00280-015-2778-8. PMID: 25994853.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db25a2fcc2be81b1c07f186225b9d746 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92881679cf35cef9a4fade3018198f08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46faf24834805cdfdea1d379d5a15e04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9090-801X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0757906e9fa5b091adf42e2f9132f0b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8162d90ebedd4f521ee2e393d17774dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4f11f214378ffef6d89bc9888a4fbbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7953a6b07cef8571be2fca0b0848515d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86781d0465a4719c847e9598d9dfbe90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c69e36610a6245a6958aa1d4798b1dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60e930c82b4eaee4891289e0181cdd26 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a62ee886ddd6f0fa770480c241cf49d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31c42164aa2740bd1970c5fca798515c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cf8aea7f2db041118be7c1d6141c935 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5399b968d4cde7dd4fead209a08a1bff
date	2015-05-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00280-015-2778-8 https://pubmed.ncbi.nlm.nih.gov/25994853
isPartOf	https://portal.issn.org/resource/ISSN/0344-5704 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664 https://portal.issn.org/resource/ISSN/1432-0843
language	English
source	https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0493669 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000378 http://id.nlm.nih.gov/mesh/D018565 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D002289Q000378 http://id.nlm.nih.gov/mesh/D011799Q000493 http://id.nlm.nih.gov/mesh/D019518
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000069347 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D018592 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005215Q000378 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015331
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Showing number of triples: 1 to 61 of 61.